B-NHL

Clinical trials for B-NHL explained in plain language.

Never miss a new study

Get alerted when new B-NHL trials appear

Sign up with your email to follow new studies for B-NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Double-Targeting CAR T-Cells offer new hope for kids with relapsed leukemia

Disease control Recruiting now

This study tests a new treatment for children and young adults (ages 3-39) with B-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to target two cancer proteins (CD19 …

Matched conditions: B-NHL

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 16, 2026 12:48 UTC

B-NHL

Get alerted when new B-NHL trials appear

Double-Targeting CAR T-Cells offer new hope for kids with relapsed leukemia